MedTrace Logo

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

NCT01602081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2015-02-11

No results posted yet for this study

Summary

The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.

Conditions

  • Anal Fistula

Interventions

DEVICE

reinforce soft tissue

reinforce soft tissue

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01602081 on ClinicalTrials.gov